107 related articles for article (PubMed ID: 15362205)
1. Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.
Tang JG; Li X; Chen P
J Zhejiang Univ Sci; 2004 Oct; 5(10):1304-12. PubMed ID: 15362205
[TBL] [Abstract][Full Text] [Related]
2. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
9. Association of Epstein Barr Virus (EBV) with nasopharyngeal carcinoma (NPC).
Shah SH; Soomro IN; Haroon S; Moatter T
J Pak Med Assoc; 2000 Jun; 50(6):182-3. PubMed ID: 10979624
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
[TBL] [Abstract][Full Text] [Related]
11. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Horikawa T; Yoshizaki T; Sheen TS; Lee SY; Furukawa M
Cancer; 2000 Aug; 89(4):715-23. PubMed ID: 10951332
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas.
Zhang Y; Peng J; Tang Y; He J; Peng J; Zhao Q; He R; Xie X; Peng X; Gan R
Jpn J Infect Dis; 2010 Mar; 63(2):132-5. PubMed ID: 20332578
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
15. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
16. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
[TBL] [Abstract][Full Text] [Related]
17. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of matrix metalloproteinase 9 in mucosal natural killer/T cell and mature T cell lymphomas and its relation to Epstein-Barr virus infection].
Feng ZY; Mo XL; Shao CK; Su ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1338-40. PubMed ID: 17884772
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1.
Nakao K; Mochiki M; Nibu K; Sugasawa M; Uozaki H
Otolaryngol Head Neck Surg; 2006 Apr; 134(4):639-45. PubMed ID: 16564389
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
